ArticleCatheterization and cardiovascular interventions : official journal of the Society for Cardiac Angiography & Interventions2025
Serial Changes in Right Ventricular Outflow Tract Gradient and Endocarditis Risk After Transcatheter Pulmonary Valve Replacement.
Article in Catheterization and cardiovascular interventions : official journal of the Society for Cardiac Angiography & Interventions, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 1 paper.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
1 citing paper in PubMed.
- Medical Versus Surgical Therapy of Infected Percutaneous Pulmonary Valve.Pediatric cardiology · 2026Article
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
11 authors.
Funding
Abstract
backgroundInfective endocarditis (IE) after transcatheter pulmonary valve replacement (TPVR) remains a significant concern. Although there are overall good short-term and long-term hemodynamic outcomes, limited data exist comparing postimplantation echocardiographic findings leading to IE.
objectivesTo compare the progressive echocardiographic performance of percutaneous implanted pulmonary valves before the development of IE.
methodsThis is a single-center retrospective cohort study of all patients who underwent successful TPVR using either Medtronic Melody or Edwards Sapien valves from 2009 to 2021. Patient demographics, procedural details, and yearly echocardiographic findings were collected and compared as appropriate. The risk of IE was compared between groups defined by baseline characteristics using time-to-event methods. Joint modeling was used to evaluate the association between peak-to-peak gradient trajectories over time and the risk of IE. The predictive performance of using peak-to-peak gradient thresholds to predict IE was evaluated using receiver operating characteristic (ROC) analyses.
resultA total of 226 patients underwent successful TPVR of which 26 patients developed IE. The annualized incidence of IE was 2.96 per 100 patient years. Patients with and without IE had similar ages, weights, and diagnoses. All IE cases were with the Melody valves. Patients who had higher postimplantation echo-derived peak instantaneous gradients (PGs) were significantly more likely to develop IE. Patients with immediate postimplant invasive peak to peak gradient ≥ 15 mmHg were more likely to develop IE. Higher PGs over time were significantly associated with a higher risk of IE (HR 1.04 per mmHg; 95% CI: 1.00-1.07, p = 0.03). ROC analyses indicate that PGs over time have poor predictive performance of IE.
conclusionEchocardiographic performance following TPVR was generally acceptable and similar to other studies. Patients who ultimately developed IE trended to have higher PPG post-TPVR and higher gradients over time before the development of IE. The rate of change of echo-derived gradients in patients with lower initial invasive gradients was more pronounced. These findings suggest that longitudinal monitoring of echocardiographic gradient could provide targeted surveillance in those identified at higher risk for IE.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.